James S. Scibetta is President at Pacira Pharmaceuticals, Inc. (PCRX). They have made 9 open-market trades across 3 companies since 2011, most recently 2021-06-19.
CIK 0001396814
4 open-market purchases totalling $435K since 2011, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AQST | BUY | 2019-08-19 | 2019-08-22 | $3.79 | $87K | -6.3% | -20.7% | +45.6% |
| MTNB | BUY | 2017-09-07 | 2017-09-07 | $1.29 | $6K | -10.1% | -2.2% | +4.3% |
| PCRX | SELL | 2017-06-05 | 2017-06-07 | $43.32 | $170K | +2.9% | +16.1% | -15.0% |
| PCRX | SELL | 2017-05-15 | 2017-05-17 | $51.20 | $1.0M | -5.9% | -12.3% | -23.2% |
| PCRX | SELL | 2017-01-17 | 2017-01-19 | $38.53 | $1.5M | -5.8% | +8.2% | +10.3% |
| PCRX | SELL | 2016-11-15 | 2016-11-17 | $36.50 | $730K | -13.3% | -10.7% | +20.1% |
| PCRX | SELL | 2016-08-15 | 2016-08-17 | $45.21 | $1.1M | -8.2% | -1.6% | -12.6% |
| PCRX | BUY | 2015-09-11 | 2015-09-14 | $61.37 | $307K | -18.1% | +0.8% | +0.8% |
| PCRX | SELL · 10b5-1 | 2015-02-06 | 2015-02-09 | $111.22 | $1.7M | -18.1% | +0.8% | +0.8% |
| PCRX | SELL · 10b5-1 | 2014-11-07 | 2014-11-12 | $87.18 | $1.3M | -18.1% | +0.8% | +0.8% |
| PCRX | SELL · 10b5-1 | 2014-08-08 | 2014-08-11 | $99.63 | $1.5M | -18.1% | +0.8% | +0.8% |
| PCRX | SELL · 10b5-1 | 2014-05-08 | 2014-05-09 | $75.05 | $1.1M | -18.1% | +0.8% | +0.8% |
| PCRX | SELL · 10b5-1 | 2013-12-30 | 2014-01-02 | $55.55 | $556K | -18.1% | +0.8% | +0.8% |
| PCRX | SELL · 10b5-1 | 2013-09-30 | 2013-10-02 | $46.74 | $467K | -18.1% | +0.8% | +0.8% |
| PCRX | SELL · 10b5-1 | 2013-06-28 | 2013-07-02 | $28.05 | $281K | -18.1% | +0.8% | +0.8% |
| PCRX | SELL · 10b5-1 | 2013-03-28 | 2013-04-01 | $28.49 | $285K | -18.1% | +0.8% | +0.8% |
| PCRX | BUY | 2011-02-15 | 2011-02-16 | $7.04 | $35K | -18.1% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.